ArticleTrials2020

Downstream or upstream administration of P2Y12 receptor blockers in non-ST elevated acute coronary syndromes: study protocol for a randomized controlled trial.

Giuseppe Tarantini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.